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This is Part I of what will be a 2-part
monograph, and consists of 5 largely un-
related papers on trial methodology. Two
of these are of particular interest, because
they take a sample ofreal trials in an attempt
to characterize how trials are actually done
in practice.
Bardelli and Saracci show that, whilst
half of the chemotherapy and radiotherapy
trials they studied were randomized, very
few of the immunotherapy trials were. They
also show that most cancer trials do not
attempt to monitor the quality of life in any
useful way. I cannot whollyshare their dismay
at this, however, because having to answer
several questions relating to quality of life
at each follow-up in a clinical trial may
generate an alarmingly large amount of
data which serves only to demonstrate the
obvious. However, it would certainly be
preferable if the percentages of patients
suffering alopecia, vomiting, ulceration,
serious infection and even death in response
to chemo- or radio-therapy were more
commonly reported.
Pocock, Armitage and Galton have studied
a random sample of the cancer trials listed
by the UICC, and find that most of the
trials they studied were not even trying to
enter large numbers of patients, over 80 00
of trials aiming to enter under 200 patients.
This means that even if a moderate but
medically important difference really does
exist between the treatments being compared
in a typical clinical trial, random differences
between the two small treatment groups
are likely to mask the demonstration of this
difference; whereas conversely, quite large
apparent differences may appear just by
chance, especially in trials with fewer than
100 patients.
Gehan describes a particular mathematical
method (Cox's method) for adjusting for
prognostic features when analysing clinical
trials. Cox's method is valid and is in some
important ways optimal for this purpose,
but it has the disadvantage that non-statisti-
cians cannot follow it, neither in detail nor
even in principle, and so, where possible,
simple retrospective stratification may be
preferable, as the underlying principles are
easier to explain to non-statisticians. Gehan,
as an example of Cox's method, tries to
correct for some systematic differences be-
tween a group of actively treated breast-
cancer patients and a group of historical
controls. This might, however, be a mis-
leading example, not only because these
groups might also have differed in various
respects which were not measured, but also
because any purely random errors in the
measurement of prognostic information can
be shown to result in incomplete adjustment
for any systematic biases that might exist.
Magnus and Miller discuss methodological
considerations that might govern any future
prophylactic cancer trials that are under-
taken. It is difficult to imagine a more
thorough article being written on this
subject, but it is difficult to evaluate a
discussion of the difficulties inherent in a
class of studies which as yet hardly exists.
Finally, there is a chapter by Higgins on
legal and ethical problems, which is probably
unique among publications on these questions
in being almost too brief.
R. PETO
Tumours-Basic Principles and Clinical
Aspects C. J. Louis (1978) Edinburgh:
Churchill Livingstone. 334 pp. £4.95.
This small paperback volume attempts to
encompass the aetiology, pathology and
treatment of malignant disease. In 300 small
pages this is clearly a difficult undertaking,
and perhaps the author has not been
altogether equal to the task. The first section
on the biology of cancer is really very
disappointing. The author uses very little
recent information of great importance for
trainee physicians. In particular, none of
the newer biology of invasion and meta-
stasis is referred to at all. Similarly the
same has to be said for the chapters on the
biology of the cancer cell, chemical carcino-488 BOOK REVIEWS
genesis and, particularly, viral carcinogenesis.
On these subjects, the guides for further
reading refer very largely to older literature
of the 1950s and 1960s. Consequently there
are many inaccuracies in the text relating
to the biology of cancer, because the more
recent literature has not been assimilated.
The clinico-pathological sections on specific
cancers are adequate but little more than a
disguised summary of many standard text-
books of pathology. Again the enquiring
student would almost certainly want to be
referred to more recent clinico-pathological
literature than is invariably quoted here in
the guides for further reading.
It is unlikely that this book will become
compulsory reading for British medical
undergraduates, though it may be of help to
young science graduates in the various
fields of cancer research, and nurses and
para-medical workers may also find it a
useful introduction. The reviewer is left
with the feeling that this book is too con-
densed, inaccurate in parts, and already out
of date.
H. BUSH
Biosynthetic Products for Cancer Chemo-
therapy. Vol. 1 G. R. PETTIT (1977) New
York and London: Plenum Press. xii + 215
pp. £12.29.
This is a book written by an acknowledged
expert in the field of naturally occurring
anti-cancer agents. His long association with
the pioneering activities of the National
Cancer Institute teams involved in screening
for anti-tumour agents is clearly evident
in this highly readable and timely publica-
tion. Furthermore, the consistent style and
approach derived from a writer as author
rather than as editor has paid dividends here.
A much appreciated feature of this book
is the careful thought given to the clear
representation of the chemical structures of
155 of the large number of the agents de-
scribed, but, at one ortwo structural formulae
per page, is sometimes a luxurious use of
space. However, the clear cross-referencing
in the text, particularly to the extensive
reference list is very welcome. Throughout,
synonyms and drug code names are included,
as well as limited dosage information in
many cases. The index is good and provides
a rapid means of identifying the natural
product.
The book is grouped essentially according
to chemical structures. The first chapter,
however, reviews the success of modern
chemotherapy of cancer both in single and
combination drug-treatment modes. Al-
though some reference is made to the carcino-
genic action of some of the chemicals in the
environment, possible later cancers after
successful combination regimes, such as
MOPP treatment of Hodgkin's disease, are
not referred to.
The second chapter is a historical intro-
duction to the use of naturally occurring
substances as anti-neoplastic agents, making
special reference to the current interest in
natural products as anti-tumour agents in
Western countries, as well as in the People's
Republic of China. Justifiable reference is
also made to the valuable contributions to
the literature of anti-cancer plant products
by Jonathan Hartwell in a series of detailed
historical listings which he published from
1950 to 1971. From the mid-60s, extracts of
arthropods and marine organisms have also
been included in the survey, some 10 0 of
which have shown anti-tumour activity.
Three chapters separately consider higher-
plant terpenoids, steroids, and alkaloids
(and associated nitrogenous products). A
chapter includes the products of fungi and
a few bacteria, which show an astonishing
variety of chemical structures with anti-
tumour activity, many of which are very
complex, but nevertheless illustrated in full.
The final chapter deals with the increasingly
interesting, chemically simpler, groups of
agents being isolated from marine organisms.
A highly commendable feature of the whole
book is the anecdotal style of writing,
suggesting a very broad in-depth fascination
with both the historical and geographical
associations of his subject. His careful
recognition of the pioneering work of other
groups is maintained throughout. One is
left wondering how the discovery of anti-
tumour agents from Asian butterflies' wings,
Taiwan stag beetles and Tahitian sea
anemones were in fact made!
Vol. 2. Eds: G. R. PETTIT and G. M. CRAGG
(1978) New York and London: Plenum
Press. ix + 150 pp. £17 approx.
This second volume is a tabular summary
of all the better-known naturally occurring
anti-cancer and cytotoxic substances appear-